公司研发支出 - 公司在2023财年研发支出约为12.1亿美元，其中包括对人工智能等技术的投资[1] GE分拆 - GE最近完成了分拆成三家独立公司的过程，这可能会使人们更关注GE HealthCare的表现[2] - GE前首席执行官表示，由于想要投资医疗行业的人可能不愿意投资制造飞机发动机的企业，因此GE HealthCare在分拆后可能会吸引更多投资者[5]

GE HealthCare Technologies Inc. 2024年第一季度业绩预测 - 预计GE HealthCare将报告强劲的有机收入增长，受益于新产品推出和客户需求增长[3] - 影像业务预计将受益于全球医疗保健提供商持续投资，手术程序需求增加[5] - 分子影像、计算机断层扫描和磁共振成像的需求旺盛，支持收入增长[6] - 超声波业务有望受益于心血管、一般成像和妇科产品的强劲表现[7] GE HealthCare Technologies Inc. 2024年第一季度业绩预期 - Zacks对公司2024年第一季度营收的预期为48.1亿美元，每股收益预期为90美分[12] GE HealthCare Technologies Inc. 2024年第一季度商业表现 - 第一季度的商业表现可能受到具有挑战性的宏观经济环境和货币风险的影响[11] GE HealthCare Technologies Inc. 股票信息 - 公司目前的股票排名为Zacks Rank 3[14]

经纪推荐 - 投资者在做出股票买入、卖出或持有决策之前通常会参考华尔街分析师的推荐[1] - GE HealthCare目前的平均经纪推荐（ABR）为1.86，介于1到5之间（强烈买入到强烈卖出），由14家经纪公司的实际推荐计算得出[2] - 8家经纪公司中有8家强烈推荐买入GE HealthCare，占所有推荐的57.1%[3] - 经纪推荐虽然建议购买GE HealthCare，但仅凭此信息做出投资决策可能不明智，因为多项研究表明，经纪推荐对指导投资者选择潜力最大的股票并没有太大帮助[4]

The latest trading session saw GE HealthCare Technologies (GEHC) ending at $86.21, denoting a +1.96% adjustment from its last day's close. This move outpaced the S&P 500's daily gain of 1.2%. Meanwhile, the Dow gained 0.69%, and the Nasdaq, a tech-heavy index, added 1.59%.The medical technology company's shares have seen a decrease of 4.5% over the last month, surpassing the Medical sector's loss of 5.82% and falling behind the S&P 500's loss of 4.16%.Investors will be eagerly watching for the performance o ...

GE HealthCare Technologies Inc. (GEHC) recently announced the expansion of its relationship with Elekta. The new collaboration follows the closing of GEHC’s acquisition of MIM Software Inc., which added the MIM SurePlan and MIM Symphony families, MIM Maestro and MIM Encore, among others, to its product portfolio.The collaboration is aimed at accelerating innovation in software solutions that will likely improve workflows, increase throughput and enhance user experience for clinicians. It is also expected to ...

The latest trading session saw GE HealthCare Technologies (GEHC) ending at $84.55, denoting a +0.07% adjustment from its last day's close. This change lagged the S&P 500's 0.87% gain on the day. On the other hand, the Dow registered a gain of 0.67%, and the technology-centric Nasdaq increased by 1.11%.Heading into today, shares of the medical technology company had lost 5.84% over the past month, outpacing the Medical sector's loss of 6.67% and lagging the S&P 500's loss of 3.97% in that time.The upcoming e ...

GE HealthCare Technologies Inc.最新产品发布 - GE HealthCare Technologies Inc.最近推出了Voluson Signature 20和18超声系统，完全整合了人工智能（AI）、尖端工具和人体工程学设计，以加快临床医生的检查时间，同时为影响女性健康的各种疾病提供更清晰的图像[1] - 最新技术可以帮助专业人士在诊断和治疗决策中更加自信，受益于高性能硬件和可调整、可扩展的软件的结合[2] GE HealthCare Technologies Inc.股票表现 - GEHC股票过去六个月上涨了29.8%，而行业上涨了8.9%，标普500指数在同一时间段上涨了17.3%[3] GE HealthCare Technologies Inc.人工智能合作计划 - GE HealthCare最近宣布了与Mass General Brigham AI的长期人工智能合作伙伴关系的计划，旨在将医学成像基础模型整合到他们的人工智能研究工作中，重点关注负责任的人工智能实践[14]

GE HealthCare Technologies (GEHC) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Shares of this medical technology company have returned -6.3% over the past month versus the Zacks S&P 500 composite's -1.7% change. The Zacks Medical Info Systems industry, to which GE HealthCare belongs, has lost 9.7% over this period. Now the key question is: Where could the stock ...

GE HealthCare Technologies Inc. (GEHC) and the Radiological Society of North America (RSNA) recently announced their partnership to offer mammography equipment, training, and educational materials to the radiologists at Muhimbili National Hospital, part of the Muhimbili University of Health and Sciences (MUHAS), Tanzania. The deal is likely to increase screening availability and assist medical professionals in reducing the nation's breast cancer death rate.The collaboration aims to help lower Tanzania’s 50% ...

乳腺X光技术和培训 - Muhimbili National Hospital将接收最新的乳腺X光技术和高级成像培训，以帮助临床医生改善乳腺癌的检测、诊断和治疗[1] - GE HealthCare与Radiological Society of North America (RSNA)宣布合作，向坦桑尼亚Muhimbili National Hospital的放射科医生提供乳腺X光技术、培训和教育工具，以改善筛查的可及性，帮助降低该国的乳腺癌死亡率[3] - 通过早期检测和扩大临床教育的努力，该项目旨在降低坦桑尼亚50%的乳腺癌死亡率[2]